Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Notch-1 regulates transcription of the epidermal growth factor receptor through p53.

Purow BW, Sundaresan TK, Burdick MJ, Kefas BA, Comeau LD, Hawkinson MP, Su Q, Kotliarov Y, Lee J, Zhang W, Fine HA.

Carcinogenesis. 2008 May;29(5):918-25. doi: 10.1093/carcin/bgn079. Epub 2008 Mar 20.

2.

Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo.

Ekstrand AJ, James CD, Cavenee WK, Seliger B, Pettersson RF, Collins VP.

Cancer Res. 1991 Apr 15;51(8):2164-72.

3.

Localization of aberrant messenger RNA of epidermal growth factor receptor (EGFR) in malignant glioma.

Tsugu A, Kijima H, Yamazaki H, Ohnishi Y, Takamiya Y, Abe Y, Ueyama Y, Sato O, Tamaoki N, Nakamura M.

Anticancer Res. 1997 May-Jun;17(3C):2225-32.

PMID:
9216693
4.

[Study on the expression of epidermal growth factor receptor and p53 in astrocytic gliomas: evidence for a distinct genetic pathway].

Dong L, Pu PY, Wang H, Wang GX, Kang CS, Jiao DR.

Zhonghua Bing Li Xue Za Zhi. 2006 Apr;35(4):232-6. Chinese.

PMID:
16776982
5.

Fibulin-3 promotes glioma growth and resistance through a novel paracrine regulation of Notch signaling.

Hu B, Nandhu MS, Sim H, Agudelo-Garcia PA, Saldivar JC, Dolan CE, Mora ME, Nuovo GJ, Cole SE, Viapiano MS.

Cancer Res. 2012 Aug 1;72(15):3873-85. doi: 10.1158/0008-5472.CAN-12-1060. Epub 2012 Jun 4.

6.

Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity.

Ye F, Gao Q, Xu T, Zeng L, Ou Y, Mao F, Wang H, He Y, Wang B, Yang Z, Guo D, Lei T.

J Neurooncol. 2009 Sep;94(2):183-94. doi: 10.1007/s11060-009-9836-1. Epub 2009 Mar 20.

PMID:
19300910
7.

Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation.

Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, Lee J, Sundaresan T, Pastorino S, Park JK, Mikolaenko I, Maric D, Eberhart CG, Fine HA.

Cancer Res. 2005 Mar 15;65(6):2353-63.

8.

Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.

Lang FF, Yung WK, Raju U, Libunao F, Terry NH, Tofilon PJ.

J Neurosurg. 1998 Jul;89(1):125-32.

PMID:
9647183
9.

A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.

Giachino C, Boulay JL, Ivanek R, Alvarado A, Tostado C, Lugert S, Tchorz J, Coban M, Mariani L, Bettler B, Lathia J, Frank S, Pfister S, Kool M, Taylor V.

Cancer Cell. 2015 Dec 14;28(6):730-742. doi: 10.1016/j.ccell.2015.10.008. Epub 2015 Dec 5.

10.

Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas.

Andersson U, Guo D, Malmer B, Bergenheim AT, Brännström T, Hedman H, Henriksson R.

Acta Neuropathol. 2004 Aug;108(2):135-42. Epub 2004 May 18.

PMID:
15148612
11.

Uniform MDM2 overexpression in a panel of glioblastoma multiforme cell lines with divergent EGFR and p53 expression status.

Halatsch ME, Schmidt U, Unterberg A, Vougioukas VI.

Anticancer Res. 2006 Nov-Dec;26(6B):4191-4.

12.

The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors.

Kefas B, Comeau L, Floyd DH, Seleverstov O, Godlewski J, Schmittgen T, Jiang J, diPierro CG, Li Y, Chiocca EA, Lee J, Fine H, Abounader R, Lawler S, Purow B.

J Neurosci. 2009 Dec 2;29(48):15161-8. doi: 10.1523/JNEUROSCI.4966-09.2009.

13.

Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas.

Gömöri E, Pál J, Kovács B, Dóczi T.

Diagn Pathol. 2012 Jan 20;7:8. doi: 10.1186/1746-1596-7-8.

14.

Introduction of wild-type p53 enhances thrombospondin-1 expression in human glioma cells.

Harada H, Nakagawa K, Saito M, Kohno S, Nagato S, Furukawa K, Kumon Y, Hamada K, Ohnishi T.

Cancer Lett. 2003 Feb 28;191(1):109-19.

PMID:
12609716
15.

Effective silencing of EGFR with RNAi demonstrates non-EGFR dependent proliferation of glioma cells.

Vollmann A, Vornlocher HP, Stempfl T, Brockhoff G, Apfel R, Bogdahn U.

Int J Oncol. 2006 Jun;28(6):1531-42.

PMID:
16685454
16.

Wilms tumor 1 expression in malignant gliomas and correlation of +KTS isoforms with p53 status.

Clark AJ, Dos Santos WG, McCready J, Chen MY, Van Meter TE, Ware JL, Wolber SB, Fillmore H, Broaddus WC.

J Neurosurg. 2007 Sep;107(3):586-92.

PMID:
17886559
17.

Inverse correlation of epidermal growth factor receptor messenger RNA induction and suppression of anchorage-independent growth by OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in glioblastoma multiforme cell lines.

Halatsch ME, Gehrke EE, Vougioukas VI, Bötefür IC, A-Borhani F, Efferth T, Gebhart E, Domhof S, Schmidt U, Buchfelder M.

J Neurosurg. 2004 Mar;100(3):523-33.

PMID:
15035290
18.

Regulation of epidermal growth factor receptor signaling by plasmid-based microRNA-7 inhibits human malignant gliomas growth and metastasis in vivo.

Wang W, Dai LX, Zhang S, Yang Y, Yan N, Fan P, Dai L, Tian HW, Cheng L, Zhang XM, Li C, Zhang JF, Xu F, Shi G, Chen XL, Du T, Li YM, Wei YQ, Deng HX.

Neoplasma. 2013;60(3):274-83. doi: 10.4149/neo_2013_036.

PMID:
23373996
19.

Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.

Barth RF, Yang W, Adams DM, Rotaru JH, Shukla S, Sekido M, Tjarks W, Fenstermaker RA, Ciesielski M, Nawrocky MM, Coderre JA.

Cancer Res. 2002 Jun 1;62(11):3159-66.

20.

Cross-talk between Notch and EGFR signaling in human breast cancer cells.

Dai J, Ma D, Zang S, Guo D, Qu X, Ye J, Ji C.

Cancer Invest. 2009 Jun;27(5):533-40. doi: 10.1080/07357900802563036.

PMID:
19219656

Supplemental Content

Support Center